key data at isc 2023: dapt vs ivt, alteplase vs tenecteplase, and evt in large core stroke
Published 1 year ago • 215 plays • Length 3:43Download video MP4
Download video MP3
Similar videos
-
5:04
tenecteplase versus alteplase in a real-world setting
-
1:45
new data supports use of tenecteplase versus alteplase
-
12:24
endovascular thrombectomy superior to medical management for large core stroke in select2
-
4:42
endovascular therapy vs medical management for large core ischemic stroke: angel-aspect results
-
1:57
isc 2023 highlights: angel-aspect & select2
-
4:46
aramis: dual antiplatelet therapy non-inferior to alteplase in minor ischemic stroke
-
23:37
intravenous tenecteplase compared with alteplase for acute ischemic stroke in canada (the act trial)
-
1:45
should dapt be given to all non-af ischemic stroke patients?
-
1:09
global adoption of tenecteplase for acute ischemic stroke
-
3:58
should tenecteplase be routinely used for thrombolysis in acute ischemic stroke?
-
16:11
it’s time to switch to tenecteplase
-
20:16
tenecteplase vs tpa in acute ischemic stroke
-
14:24
timing and indication for pci in tavi patients with coronary disease
-
1:48
expedited recommendation for short-term dual antiplatelet therapy after minor stroke & high-risk tia
-
13:38
aortic stenosis: eacts/esc guidelines update
-
3:45
lbct clasp iid trial | tct 2022
-
1:57
multi-valve surgery risk calculator